cannabis investment
cannabis investment · page 2
- Events
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition.
- Business
How to Start a Cannabis Business: A Complete Guide
The global legal cannabis industry is no longer an emerging market, but a maturing one with established regulatory frameworks, institutional capital, and a growing ecosystem of professional services.
- Cultivation
De-Risking the Future: What’s Holding Traditional Industry Back from Cannabis Investment?
Nearly a decade after the inception of what we would now consider the ‘global cannabis industry’, Prohibition Partners forecasts its total worth to be around $40bn in 2025, already larger than the entire global recorded music industry.
- Clinical Research
Rescheduling Will Reprice Medical IP, Not Retail Footprints
US cannabis rescheduling is unlikely to trigger a land grab.
- Press releases
Cannabis Europa Launches Reimagined VIP Experience: A New Standard for Senior Decision Makers
Cannabis Europa has today unveiled a new, fully reimagined, dedicated VIP Experience focused on the needs of senior executives, investors and policymakers shaping the future of Europe’s cannabis industry.
- Investment & Finance
Real Estate, Banking, and Bankruptcy: Q3 Hits the Three Tiers of Cannabis Capital Very Differently
The story of the cannabis sector’s financial health is increasingly split between those providing the capital and those who desperately need it.
- Clinical Research
How to Read a Cannabis Research Paper
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal.
- US & Canada
Countdown to Business of Cannabis: New York 2025, Celebrating Our Pioneering Sponsors
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300 leaders from across the cannabis ecosystem for a day of strategic dialogue, networking, and market insight.
- Clinical Research
Evidence, Earnings and Expansion: Avextra Enrolls its First Patient to Landmark Italian Clinical Trial, as Market Leaders Wrangle to Maintain Dominance
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our understanding of its use cases, and more importantly, fill the long-maligned gap in clinical evidence.
- Press releases
Why You Should Attend Business of Cannabis: New York
Industry leaders, regulators and investors meet at Business of Cannabis New York to discuss funding, regulation and sustainable market growth.
- Uncategorized
What’s On the Agenda for Business of Cannabis: New York 2025?
Industry leaders, regulators and investors meet at Business of Cannabis New York to discuss funding, regulation and sustainable market growth.
- Opinion
From Growth to Discipline: PHCANN’s Vision for Pharmaceutical Cannabis in Europe
As Europe’s medical cannabis market shifts from a focus on growth to pharmaceutical discipline, PHCANN International has emerged as a leading voice in this new phase.
